6 – 10 of 12
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Non-pharmacological Effects in Switching Medication : The Nocebo Effect in Switching from Originator to Biosimilar Agent
(
- Contribution to journal › Article
- 2017
-
Mark
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)
(
- Contribution to journal › Article
- 2013
-
Mark
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
(
- Contribution to journal › Article
- 2011
-
Mark
OARSI/OMERACT Initiative to Define States of Severity and Indication for Joint Replacement in Hip and Knee Osteoarthritis. An OMERACT 10 Special Interest Group
(
- Contribution to journal › Article
- 2007
-
Mark
OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis
(
- Contribution to journal › Article